Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.78 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.78 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.78 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.78 |
| ▸ | P2RY2 | P41231 | 10/20 | 0.68 |
| ▸ | P2RY6 | Q15077 | 8/20 | 0.68 |
| ▸ | P2RY14 | Q15391 | 7/20 | 0.68 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5494169 | 1.00 | SLC28A1 (0.78) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| SCHEMBL7189865 | 1.00 | SLC28A1 (0.78) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| SCHEMBL7183641 | 1.00 | SLC28A1 (0.78) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| SCHEMBL7573342 | 0.99 | SLC28A1 (0.76) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| SCHEMBL7575088 | 0.93 | SLC28A1 (0.67) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| SCHEMBL4956688 | 0.93 | SLC28A1 (0.70) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| SCHEMBL6464709 | 0.90 | SLC28A1 (0.62) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| SCHEMBL4211565 | 0.90 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL30019440 | 0.88 | SLC28A1 (0.95) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL2912983 | 0.88 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024082546-A1 | METHOD FOR BIOSYNTHESIS OF ARABINONUCLEOSIDE BY ONE-POT METHOD, AND COMPOSITION | 凯莱英生命科学技术(天津)有限公司 | 2024-04-25 | — | — | WO | claimed |
| CN-115279891-A | Recombinant gene engineering bacterium for preparing nelarabine and application thereof | 正大天晴药业集团股份有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-111879875-A | Method for determining cytarabine and uridine arabinoside in blood plasma | 武汉伯瑞恒医药科技有限公司 | 2020-11-03 | — | — | CN | claimed |
| WO-2005090370-A1 | PHARMACOLOGICALLY ACTIVE AGENTS CONTAINING ESTERIFIED PHOSPHONATES AND METHODS FOR USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-09-29 | — | — | WO | claimed |
| WO-2024082546-A1 | METHOD FOR BIOSYNTHESIS OF ARABINONUCLEOSIDE BY ONE-POT METHOD, AND COMPOSITION | 凯莱英生命科学技术(天津)有限公司 | 2024-04-25 | — | — | WO | disclosed |
| WO-2024082545-A1 | METHOD FOR ENZYMATIC SYNTHESIS OF NUCLEOSIDE CONTAINING PROTECTING GROUP, AND COMPOSITION | 凯莱英生命科学技术(天津)有限公司 | 2024-04-25 | — | — | WO | disclosed |
| CN-115938482-A | Method for screening key genes, metabolites and pathways of spinal cord injury based on multi-group association analysis | 宁夏医科大学总医院 | 2023-04-07 | — | — | CN | disclosed |
| EP-3271468-B1 | DEAMINATION OF ORGANOPHOSPHORUS-NUCLEOSIDES | LABORATORIO TECNICO DE SEGURIDAD Y ESTANDARIZACION SL (ES) | 2022-12-14 | — | — | EP | disclosed |
| CN-115279891-A | Recombinant gene engineering bacterium for preparing nelarabine and application thereof | 正大天晴药业集团股份有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-107849594-B | Deamination of organophosphorus nucleosides | 科技学专业学院有限公司 | 2022-01-18 | — | — | CN | disclosed |
| CN-112552361-A | Cytarabine crystal, cytarabine freeze-dried powder and freeze-drying method | 瀚晖制药有限公司 | 2021-03-26 | — | — | CN | disclosed |
| CN-106929553-B | Method for synthesizing vidarabine by enzyme method | 上海鑫欣生物科技有限公司 | 2021-02-19 | — | — | CN | disclosed |
| WO-2011011710-A1 | METHODS OF TREATING VIRAL INFECTIONS | CHIMERIX, INC. (US) | 2011-01-27 | — | — | WO | disclosed |
| US-20100136536-A1 | Molecular Switches And Methods For Their Use | JOHNSON & JOHNSON RESEARCH PTY. LIMITED (AU) | 2010-06-03 | — | — | US | disclosed |
| US-20070231810-A1 | Multicomponent nucleic acid enzymes and methods for their use | SPEEDX PTY LTD (AU) | 2007-10-04 | — | — | US | disclosed |
| CN-1583776-A | Preparing method for cytarabine | HAIZHENG PHARMACEUTICAL CO LTD (CN) | 2005-02-23 | — | — | CN | disclosed |
| EP-0703787-A1 | CELL GROWTH REGULATORS | NYCOMED PHARMA AS (NO) | 1996-04-03 | — | — | EP | disclosed |
| WO-1994027632-A1 | CELL GROWTH REGULATORS | NYCOMED PHARMA A/S (NO) | 1994-12-08 | — | — | WO | disclosed |
| US-4017606-A | CYTOSINE ARABINOSIDE AND HYDROGENATED PYRIMIDINE NUCLEOSIDES | THE UPJOHN COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
| US-4017606-A | CYTOSINE ARABINOSIDE AND HYDROGENATED PYRIMIDINE NUCLEOSIDES | THE UPJOHN COMPANY (US) | 1977-04-12 | — | — | US | disclosed |